Alkermes Announces Notice of Allowance of Key US Patent for Aripiprazole …

Alkermes Announces Notice of Allowance of Key US Patent for Aripiprazole …
Aripiprazole lauroxil, which leverages the LinkeRx technology, is a once-monthly, injectable atypical antipsychotic in development for the treatment of schizophrenia. Once in the body, aripiprazole lauroxil converts to … The company has a diversified … Read more on DailyFinance

Alkermes Expands CNS Pipeline and Announces Positive Results from Phase 1 …
ALKS 3831, a proprietary drug compound for the treatment of schizophrenia, is the combination of ALKS 33, a potent opioid modulator, and the established antipsychotic agent, olanzapine. Weight gain is a common and clinically relevant side effect of … Read more on DailyFinance

Antidepressants don't increase pregnancy risk of stillbirth and death in newborn
SSRIs approved by the Food and Drug Administration to treat depression, with their generic names followed by brand names in parentheses, include: Citalopram (Celexa); Escitalopram (Lexapro); Fluoxetine (Prozac, Prozac Weekly, Sarafem); Paroxetine … Read more on Examiner.com